{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["9"],"submitter":["Visco V"],"pubmed_abstract":["During the last years, the management of heart failure (HF) made substantial progress, focusing on device-based therapies to meet the demands of this complex syndrome. In this case report, we present a multistep approach to deal with HF. Specifically, we report the first patient subjected to the implantation of both Optimizer Smart<sup>®</sup> (Impulse Dynamics Inc., Marlton, NJ, USA) and CardioMEMS devices. A 72-year-old male patient with HF and reduced ejection fraction (HFrEF) was admitted to our cardiology department in January 2021, following a progressive shortening of the time between hospitalizations for levosimendan infusions. Specifically, the patient was monitored daily by CardioMEMS, and a strategy of levosimendan infusions guided by the device had been adopted. He was also a c"],"journal":["Frontiers in cardiovascular medicine"],"pagination":["874433"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9013826"],"repository":["biostudies-literature"],"pubmed_title":["A Multistep Approach to Deal With Advanced Heart Failure: A Case Report on the Positive Effect of Cardiac Contractility Modulation Therapy on Pulmonary Pressure Measured by CardioMEMS."],"pmcid":["PMC9013826"],"pubmed_authors":["Manzo M","Vecchione C","Visco V","Fiorentino A","Ciccarelli M","Galasso G","Esposito C"],"additional_accession":[]},"is_claimable":false,"name":"A Multistep Approach to Deal With Advanced Heart Failure: A Case Report on the Positive Effect of Cardiac Contractility Modulation Therapy on Pulmonary Pressure Measured by CardioMEMS.","description":"During the last years, the management of heart failure (HF) made substantial progress, focusing on device-based therapies to meet the demands of this complex syndrome. In this case report, we present a multistep approach to deal with HF. Specifically, we report the first patient subjected to the implantation of both Optimizer Smart<sup>®</sup> (Impulse Dynamics Inc., Marlton, NJ, USA) and CardioMEMS devices. A 72-year-old male patient with HF and reduced ejection fraction (HFrEF) was admitted to our cardiology department in January 2021, following a progressive shortening of the time between hospitalizations for levosimendan infusions. Specifically, the patient was monitored daily by CardioMEMS, and a strategy of levosimendan infusions guided by the device had been adopted. He was also a c","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-04T20:37:10.929Z","creation":"2024-12-03T22:28:26.904Z"},"accession":"S-EPMC9013826","cross_references":{"pubmed":["35445087"],"doi":["10.3389/fcvm.2022.874433"]}}